This is the quality that defines how BioCare, as a strategic partner, moves to avoid a slow down of product launches and patient access.
What is speed and efficiency?
This is the quality that defines how BioCare, as a strategic partner, preserves market competition and innovation?
What is "protection against consolidation?"
We characterize ourselves as this to our current and prospective customers, especially as we call-out the mandate of others' use of formularies.
What is independence?
This is BioCareSD's policy on owning provider networks or controlling treatment decisions.
What is No Network Ownership or Formularies?
When vertically integrated distributors use their control over providers to demand price concessions from manufacturers, it does this to the market
What is Economic Pressure & Margin Erosion
This is the quality that defines how BioCare, as a strategic partner, that speaks to avoidance of tying rebates across product categories.
What are bundled rebate schemes?
This is the type of pricing BioCare aims to offer, without hidden rebates.
What is fair pricing?
This is how BioCareSD engages supplier partners in pricing discussions with manufacturers?
What is fair and transparent pricing?
This is how BioCareSD ensures product availability for our community providers.
What is direct, independent access?
This happens if manufacturers do not comply with pricing demands from vertically integrated distributors.
What is restricted market access?
This quality defines BioCare's role as a strategic partner, which speaks to the visibility we provide into sales, inventory, and market trends.
What is data transparency & support?
BioCareSD does this to ensure providers' product choice.
What is market access protection?
This is what BioCareSD offers to manufacturers regarding purchasing requirements.
What is flexibility and customization?
This is how BioCareSD avoids creating artificial supply constraints.
What is "no allocation games"?